integrated with a search algorithm to identify the cocktail based on the response of the biological system as a whole. The algorithm develops its next iteration only after feedback, in this case a series of discernible phenotypic responses. The authors used the closed-loop control scheme to reduce infection of cultured cells with a mammalian virus. This approach rapidly identified a combination of drugs that inhibited almost 100% of viral activity, with lower doses of each than would be needed alone. 
GENETICS

MicroRNA's influence on leukemia
MicroRNAs have been predicted to influence diseases by regulating hundreds of gene transcripts at a time, but few such data sets have been identified. George Calin et al. present evidence that miR-15a and miR-16-1, which are known to suppress tumors through the BCL2 oncogene, activate and inactivate many genes that are implicated in human leukemia. The authors inserted the miRNAs into the genomes of tumor cells and injected them into nude mice. The miRNA clusters completely suppressed tumor growth in three of five mice and shrunk the tumors in other mice. The miRNAs also up-regulated 265 genes and down-regulated 3,307, meaning that Ϸ14% of the estimated number of human genes were affected. Among the many genes that were down-regulated, a significant number had AU-rich elements. An analysis of the downregulated transcripts identified many genes that are activated in cancer by directly or indirectly affecting apoptosis and the cell cycle. The authors say that identifying the suite of silenced genes could help develop new therapies for leukemia. -P.D. ' 
''MiR-15a and miR-16-1 cluster functions in human leukemia
IMMUNOLOGY
Designer T cells prevent autoimmune disease in mice
Multiple sclerosis (MS) is an autoimmune disease that occurs when the body's T cells attack the fatty myelin sheath that insulates nerve fibers in the brain, spinal cord, and optic nerve. Without this protective layer, nerves are unable to send electrical signals and scars are formed. Joel Stern et al. developed regulatory T cell lines that suppress multiple autoimmune diseases in mice, including experimental autoimmune encephalomyelitis (EAE), the mouse model of MS. To create these MS-fighting T cells, Stern et al. immunized SJL/J mice with amino acid copolymers, then harvested T lymphocytes from the spleen and lymph nodes and used the lymphocytes to create cell lines. These new T cell lines secrete high levels of IL-10 and IL-13-immune chemicals that play an important role in immunosuppression. However, unlike traditional T cells, these lines only produce small amounts of IL-4 and virtually no TGF-␤, IL-17, IL-6, IL-2, IFN-␥, or TNF␣. When EAE was triggered in genetically susceptible mice, the animals developed disease at day 17 or 18. However, animals that received the IL-10-secreting T cells failed to develop EAE. The T cells also prevented the development of two other autoimmune diseases that could be induced in the same strain of mice. -B.T.
''Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice'' by Joel N. H. Stern, Derin B. Keskin, Hong Zhang, HuiJuan Lv, Zenichiro Kato, and Jack L. Strominger (see pages 5172-5176)
A mixture of drugs is often more effective than using a single effector. However, it is extremely challenging to identify potent drug combinations by trial and error because of the large number of possible combinations and the inherent complexity of the underlying biological network. With a closed-loop optimization modality, we experimentally demonstrate effective searching for potent drug combinations for controlling cellular functions through a large parametric space. Only tens of iterations out of one hundred thousand possible trials were needed to determine a potent combination of drugs for inhibiting vesicular stomatitis virus infection of NIH 3T3 fibroblasts. In addition, the drug combination reduced the required dosage by Ϸ10-fold compared with individual drugs. In another example, a potent mixture was identified in thirty iterations out of a possible million combinations of six cytokines that regulate the activity of nuclear factor kappa B in 293T cells. The closed-loop optimization approach possesses the potential of being an effective approach for manipulating a wide class of biological systems.
combinatory drug therapy ͉ drug cocktail ͉ drug resistance ͉ feedback control ͉ viral infection D iseases arise from altered cellular functions and activities. Modifying cellular activities by a combination of agonists can lead to an effective strategy for disease therapeutics. A mixture of drugs, in many cases, is more effective than using a single stimulus (1) (2) (3) (4) (5) . However, the combination of various possible concentrations of a set of agonists creates a large testing parametric space. As such, identifying the optimum combination of multiple drugs to control a complex biological system presents a major challenge (6, 7) . Here, we experimentally demonstrate that a closed-loop optimization scheme can serve as an alternative approach to trial and error, which needs to test a large number of all of the possible combinations. The approach suggested in this work effectively searches for potent drug combinations that manipulate the cellular network toward a therapeutic goal.
Cellular functions and activities are regulated by complex networks of signaling and regulatory pathways. The current approach aims to circumvent the need for detailed information of biological signaling and regulatory networks. To experimentally implement the closed-loop optimization approach for searching for a potent drug mixture, combinations of cytokines and drugs are applied to stimulate the system of interest. Biomarkers indicating the biological responses of interest, such as viral activity, are then evaluated. Based on the biological responses, a stochastic search algorithm chooses a new drug mixture for the next test. Iteratively, the closed-loop control scheme will drive the systems to desired phenotypic responses (Fig. 1) . We have demonstrated that only tens of iterations out of a large number of possible combinations are needed. This effort-saving approach actively manipulates the complex biological systems as a whole, rather than analyzing the processes through individual signaling pathways in a network.
The closed-loop control can serve as a generic approach in devising multidrug therapies against wide classes of pathogens and diseases. We have chosen two model systems to explore this closed-loop optimization approach. In the first system, we consider combinations of interferons (IFNs) and antiviral drugs for inhibiting viral activity. Specifically, vesicular stomatitis virus (VSV) infection of NIH 3T3 fibroblasts was used as the model system. Although a combination of cytokines and drugs is known to have a stronger antiviral activity than that from a single agent, the complex interactions among the pathways and the large parametric space constituted by the combinatorial drugs impose a major challenge to identifying potent combinations. In the second system, the activity of nuclear factor kappa B (NF-B) was chosen as the endpoint. The therapeutic effect of combinatorial cytokines on human embryonic kidney 293T cells was explored by searching for a potent combination of cytokines for maximizing the activity of NF-B. NF-B regulates expression of several genes that mediate the inflammatory responses and cell proliferation, and is one of the major therapeutic targets for chronic inflammatory disease and cancer (8, 9) .
Results
Stochastic Search Algorithm. Stochastic search algorithms constitute one of the most effective approaches to solving large-scale combinatorial optimization problems of highly complex systems. Stochastic search algorithms do not require training of data to form a metamodel as in surrogate-based optimization (e.g., neural networks) (10) . Therefore, only a small number of experiments is typically required. Simulated annealing (11), genetic algorithms (12), ant colony optimization (13) , and Gur Game (14) are some of the well established stochastic search algorithms. These algorithms have been demonstrated in a variety of applications, such as crystal structure predications (11) , routing in communication networks (13) , and distributed control in robotics (16, 17) . These methods have also been applied in computational biology (18) and protein-folding stud-ies (19) . A major goal of the current study is to demonstrate the stochastic search approach to find effective drug combinations and to show that fast convergence, that is, a small number of iterations, can be achieved.
Several stochastic search algorithms can potentially be applied for regulating complex biological systems. In this work, we selected the Gur Game to demonstrate the closed-loop optimization approach. Similar to other stochastic search algorithms, the Gur Game does not require detailed information about the biological system or how the system responds to manipulation of input variables. The property of rapid convergence of the Gur Game is invaluable for experimental manipulation of complex biological systems with a large parametric space. Furthermore, it is robust to random noise and nonlinear changes in the system and the environment, which are commonly observed in a biological system. The Gur Game is based on biased random walks of the input states (drug concentrations) collectively driving the system (a cell) toward higher performance (the biological activity). The principle and implementation of the approach are illustrated by a simplified example of searching antiviral drugs in Fig. 2 . More details of the Gur Game are discussed in the supporting information (SI) Appendix.
Drug Cocktails for the Inhibition of Viral Activity. We have applied the approach of closed-loop control to search for effective drug combinations for the inhibition of viral activity. VSV infection of NIH 3T3 fibroblasts was used as the model system in this investigation. Several antiviral agents, including IFN␣, IFN␤, IFN␥, puromycin, and ribavirin and their combinations, were considered. The virus was genetically engineered with a green fluorescent protein (GFP) reporter for assessing the infection to the host cells (20) . Cells were cultured in 96-well plates to 60-80% confluence before the experiment. VSV and drug combinations were applied to the cells at the beginning of each iteration. The percentage of cells expressing GFP were counted and fed into the Gur Game algorithm for determining the drug combination in the next iteration. A new batch of cells was applied for each experiment. In our control experiments, which were performed throughout this investigation, Ͼ95% of the cells were infected and expressing GFP when incubated with VSV at a multiplicity of infection of 1 (data not shown). The morphology and doubling rate of the cells were monitored throughout the experiment.
Closed-Loop Optimization of Potent Drug Cocktails. Four sets of experiments were performed in this investigation. All five agents, IFN␣, IFN␤, IFN␥, puromycin, and ribavirin, were considered for sets 2 to 4. For set 1, only IFN␣, IFN␤, and IFN␥ were considered. For set 1 and set 2, six concentrations were assigned for each agent whereas ten concentrations were considered in set 3 and set 4 (see SI Tables 2-5 in SI Appendix). Ten concentrations each of five drugs led to one hundred thousand (10 5 ) possible combinations. For set 1 and set 2, initial concentrations were zero for all agents and random initializations were applied for set 3 and set 4. The antiviral activity, which is defined as the percentage of cells not expressing GFP after incubation with VSV for 13 h, was considered as the output biological response for the optimization of the drug mixture. The percentage of cells expressing GFP was counted after incubation with VSV and the drug mixture. According to this information, the Gur Game determined the concentration of each drug for the next iteration (see SI Appendix for details). These processes were repeated during each iteration. In the experiment, set 2 rapidly The procedure of performing the Gur Game for searching for the best concentration of the antiviral drug is shown in Middle and Bottom. In the experiment, the AVA is first tested and expressed as a number between 0 (0% AVA) and 1 (100% AVA). A random number between 0 and 1 is generated after each test. If the AVA is smaller than the random number, then the concentration will be switched in the next iteration. Otherwise, the drug concentration will stay in the next iteration. In this example, the system has a higher chance to stay at concentration C2 and to switch at concentration C1. This asymmetric decision provides the ''bias'' of the search that leads the concentration toward high AVA. The random number introduces ''randomness'' in the decision, because the concentration of the drug may switch even at a high AVA. As a result, the search will not be trapped at a drug concentration of a local maximal biological response. (b) A hypothetical experiment is shown to illustrate the procedure. In this example, it can be proven mathematically that the chance of the system to choose the drug concentration C2 (AVA ϭ 0.8) will be 0.75, whereas the probability of choosing drug concentration C1 (AVA ϭ 0.4) is 0.25 (see SI Appendix). (c) The procedure can be extended to multiple drugs with different concentration levels each. An example of two drugs with four concentrations each is shown. Each drug is assigned with a set of discrete concentrations, represented by Ϫ2, Ϫ1, 1, and 2. After each experiment, a random number is generated for each drug. If the random number is larger than AVA, the concentration will be switched. Otherwise, the concentration will either stay or be switched in an attempt to further improve the performance (see SI Appendix). The random number introduces randomness in the search and the system collectively ''biases'' toward drug combinations with potent antiviral effects. Therefore, the procedure implements a ''bias random walk'' of drug concentrations to search for potent drug cocktails.
reached a potent combination that totally inhibited the GFP expression and converged to the solution in less than ten iterations (Fig. 3 ). This is likely because of the smaller set of concentrations applied in set 2. Similarly, set 3 and set 4 converged to potent combinations that inhibited 100% of viral activity after 12 and 14 iterations, respectively. The results of set 3 are listed in Table 1 to illustrate a typical iteration of the search process. However, set 1 containing only three types of IFN reached a maximum viral inhibition value of Ϸ0.63, that is, 63% of the cells were not expressing GFP.
Cytokine Combinations for Activating NF-B.
To illustrate that the closed-loop control scheme can be applied in different biological systems, we searched for cytokine combinations that regulate NF-B activity in 293T cells. Six cytokines (TNF␣, TNF␤, IL-1␣, IL-1␤, EGF, and BAFF) were considered for regulating the NF-B activity. The six stimuli, belonging to three families of cytokines and growth factors, represent various possibilities of pathway interactions: (i) effectors trigger different receptors and mechanisms of a single-pathway component, and/or (ii) parallel pathways are triggered simultaneously, each of which exerts effects on a subsequent phenotype. Tumor necrosis factor (TNF) and interleukin 1 (IL-1) are commonly used for stimulating the NF-B signal transduction pathway (21) . Although TNF␣, TNF␤, IL-1␣, and IL-1␤ have similar functions, they are known to have distinct roles in the cellular responses (22) . Stimulation with TNF␣ and IL-1␤ simultaneously was reported to activate NF-B (23) and other cellular functions (24) synergistically. The effect of epidermal growth factor (EGF) on NF-B signaling is cell-type specific. For example, EGF has been reported to up-regulate NF-B activity in several cell lines that have high levels of EGF receptor expression (25) . However, EGF does not enhance NF-B activity in human microvascular endothelial cells (26) and suppresses oxidant-induced NF-B activity in intestinal epithelial cells (27) . BAFF (B cell-activating factor belonging to the TNF family) has been shown to activate NF-B by a NF-B essential modulator (NEMO) (IKK␥) independent pathway in maturing B cells (28) . The possible interactions of the six cytokines and the resulting combinatorial effects on NF-B in 293T cell are not fully understood. In this study, each agonist was assigned 10 discrete concentrations: 0, 0.25, 0.5, 1, 2.5, 5, 10, 25, 50, or 100 ng/ml. The values spanned over three orders of magnitude in concentration. The concentrations were selected to maximize the range to be considered while maintaining acceptable resolution in cytokine concentrations (i.e., the difference between concentrations). The lowest concentration that showed an observable effect was between 0.25 and 1 ng/ml. Concentrations Ͼ100 ng/ml resulted in a considerable amount of cytotoxicity and, therefore, were not considered in this study. Ten concentrations each of six cytokines led to one million (10 6 ) possible combinations in the search space.
Closed-Loop Optimization of NF-B Activity. The closed-loop optimization experiment started with choosing a set of cytokine concentrations. Then, the cells cultured inside a microfluidic channel were transiently stimulated with the set of cytokines for one hour. The duration is based on previous reports of the dynamic of NF-B and selected so that no oscillatory response of the NF-B will take place (29) . The fluorescent light is linearly proportional to the NF-B expression level (30) . The GFP fluorescence intensities of individual cells were recorded seven hours after the stimulation at the peak time point of the fluorescence induction. The average GFP intensity of Ϸ100 cells was fed to the Gur Game. According to the intensity, the Gur Game determined the concentration of each cytokine for the next iteration. These processes were repeated during each iteration. At the beginning of the experiment, the cytokine concentrations were chosen randomly by the Gur Game to explore cytokine combinations with high NF-B outputs (Fig. 4  a and b) . The system was not trapped by several cytokine combinations with apparently high outputs, e.g., iteration 14. Near iteration 12, the algorithm ''detected'' a promising trend. Four cytokines (TNF␣, TNF␤, IL-1␣, and IL-1␤) were driven to higher concentrations but the other two (EGF and BAFF) were driven to lower concentrations. At iteration 17, the system determined a potent combination of cytokines for activating the NF-B. Because of the random walk nature of the Gur Game, the algorithm did not settle with the large performance gains at iteration 17. The most potent cytokine combination was (TNF␣ ϭ 25 ng/ml, TNF␤ ϭ 50 ng/ml, IL-1␣ ϭ 50 ng/ml, IL-1␤ ϭ 50 ng/ml, EGF ϭ 2.5 ng/ml, BAFF ϭ 2.5 ng/ml). The random walk nature of the algorithm continually looked for other states with better performance, and the reward function decreased significantly several times during the search. However, the system returned to the similar NF-B activity at iterations 23 and 28. A comparison between NF-B activities under stimulation of TNF␣ and the cytokine combination is shown in Fig. 4c . The searching paths are shown in Fig. 4 d and e.
Discussion
In the viral infection experiment, we have shown that potent drug combinations can be identified rapidly by using a closed-loop optimization approach. With only tens of experiments, potent drug combinations, which can inhibit close to 100% of VSV activity in NIH 3T3 cells, have been identified. The closed-loop optimization scheme not only enhances the antiviral activity of cytokines and drugs, but also minimizes their dosages. To elucidate the effectiveness of drug cocktails, we compared the antiviral activity of a potent drug mixture (IFN␣ ϭ 3.9 pg/ml; IFN␤ ϭ 0.05 ng/ml; IFN␥ ϭ 30 ng/ml; puromycin ϭ 12.5 g/ml; ribavirin ϭ 12 g/ml) with individual drugs. If a single drug is applied, much higher concentrations are required. Fig. 5a shows the dosages required for completely inhibiting the viral activity by using the potent drug combination. If applied individually, concentrations of 100 g/ml and 25 g/ml (Fig.  5b) were required for ribavirin and puromycin, respectively. Interferons were not able to totally inhibit the viral activity in the concentration range tested (up to 10 mg/ml). However, the drug combination identified by the Gur Game reduced the required dosage by 10-fold for individual drug. For example, only 12 g/ml of ribavirin (Fig. 5a ) is needed in combinatory drugs, but 100 g/ml of rivavirin (Fig. 5b) is needed for single-drug treatment for 100% inhibition of viral infection. Fig. 5c shows the percentage of viral inhibition for applying single drugs at the concentrations in the potent combination. The data indicate the effectiveness of using drug combinations for inhibiting the viral activity. Inhibiting viral activity with low-dosage combinations provides new opportunities in antiviral therapeutics, because high dosage always associates with cytotoxicity and other side effects on biological systems. As shown in Fig. 4c , the activity of NF-B activated by the drug combination is significantly higher than TNF␣, which is a cytokine applied in numerous NF-B studies. It further indicates that a mixture of drugs is often more effective than using a single stimulus. Furthermore, combinatorial drugs are involved in actions among multiple pathways in the network. The effective closed-loop control scheme may open up a new paradigm for facilitating the study of interactions among the various mechanisms involved.
In the viral inhibition experiment, set 1 did not converge to a drug combination that can inhibit the viral activity completely. In fact, when the three interferons were used individually, the highest viral inhibition observed in our experimental conditions was Ϸ15% at 100 ng/ml of IFN␤. The IFN combination identified in iteration 16 of set 1 is (IFN␣ ϭ 1.3 pg/ml, IFN␤ ϭ 1 ng/ml, and IFN␥ ϭ 50 ng/ml) and can inhibit Ͼ50% of VSV activity. The other three independent tests (set 2, set 3, and set 4) started with very different initial drug combinations, and they all converged to the prevention of the viral infection within 15 iterations. This indicates the rapid convergence of the closed-loop optimization approach for searching for potent drug combinations. This result shows the search scheme can arrive at 100% inhibition with different initial conditions in the viral infection experiment. As reflected by the fast convergence of set 2, fewer concentrations within the range results in fast searching of the space. In general, several parameters should be considered during the experimental design of a Gur Game study. The concentration of the drug and the reward function, that is, the outputs of biomarkers indicating the desired phenotypes, should be adjusted to fine tune the balance between the robustness, converging rate, and the ability to escape from local peaks. In our experiment, we increased the ''randomness'' with a larger step size to improve the chance for the drug combinations to escape from local optima while maintaining the resolution of the drug concentration. If necessary, multiple experimental investigations can be performed to identify the optimal configuration for the optimization experiment. In the current study, the Gur Game rapidly identifies potent cytokine and drug combinations in the search space in both model systems. In principle, even a larger parametric space, for example, 7, 8, or more cytokines with 10 7 , 10 8 , or more combinations, is expected to achieve a similar rapidly converging rate by using a stochastic search (see also the SI Appendix for further discussion).
The robustness of the approach was also illustrated by the observation that the paths by which the cytokine combinations moved toward the peak were different in the NF-B experiment (Fig. 4 d and e) . The system did not settle with the particular cytokine combination at iteration 17 because of the random walk nature of the Gur Game. The Gur Game continuously searched for other regions in the search space, that is, different combinations of cytokines. The system states moved away and again reached the peak response (iterations 23 and 28) along several different paths, indicating the effectiveness of the search algorithm. Because the Gur Game determines the next states only according to the current states, every iteration can be considered to be an initial search. This resembles the random initialization in other gradient search schemes (15) .
With the potent combination of cytokines efficiently determined by the closed-loop optimization scheme, we then varied the concentration of a specific cytokine while holding others constant to understand the sensitivity of that cytokine and to verify our search result (Fig. 6) . TNF␣ was found to be the most sensitive in the combination in affecting the activity of NF-B. Elimination of TNF␣ in the cytokine combination resulted in a Ϸ50% decrease in fluorescence intensity. Total elimination of any one of TNF␤, IL-1␣, or IL-1␤ resulted in Ϸ30% decrease in GFP intensity. The effects of IL-1␣ and IL-1␤ were not very sensitive to their concentrations in the range of 25-50 ng/ml. When combined with the potent cytokine combination, EGF decreased the NF-B activity with increasing dose concentration. It should be noted that EGF alone did not show a strong effect on the NF-B activity in 293T cells (data not shown). For the case of BAFF, it had a minimal effect on NF-B activity with or without the potent cytokine combination. It was also very interesting to note that the Gur Game suggested lower and lower concentrations of both EGF and BAFF as the iterations proceeded (Fig. 4a) . Therefore, the Gur Game algorithm confidently locates the most favorable concentrations for each cytokine, and there is no indication that a more effective combination exists in the entire search space. These data also indicate that the effects of individual cytokines are not additive in the combinatorial tests and the interactions among pathways are nonlinear.
With a stochastic search algorithm to use the output information obtained from the biological response, the closed-loop optimization approach can effectively search for a potent drug mixture without the need for detailed information about the effects of each agent on the networks of pathways. We also found that a much lower dosage is required with the drug mixture compared with individual drugs in the viral infection experiment. In addition, new phenomena can be identified for furthering our understanding of the complex nonlinear interactions in a broad class of biological systems with this approach.
Methods
Materials. Cell culture medium was supplied by Cellgro. Plasmid was purchased from Clontech. Lipofectamine 2000 transfection reagent was purchased from Invitrogen. All other reagents and chemicals were supplied by Sigma unless stated otherwise. Viral Infection. GFP-tagged vesicular stomatitis virus (VSV) was prepared by propagation of virus on confluent monolayers of MDCK cells. Supernatant from infected cells were cleared of debris by centrifugation and spun at Ͼ100,000 ϫ g through a 25% sucrose cushion by using a Beckman SW28 rotor for 2 h. Virus pellet was gently rinsed and resuspended in PBS. Viral titers were determined by using standard plaque assay procedures on monolayers of MDCK cells. For all experimental infections cells were incubated with viral inoculums at a multiplicity of infection of 1.
Plasmid Construction and Cell Line Establishment. The expression construct pCEP4-NF-B-d2EGFP was generated by cutting out the NF-B-d2EGFP fragment from pNF-B-d2EGFP vector at BglII and AccI sites and inserting it into pCEP4 vector, which has EBNA-1 and oriP to maintain episomal DNA replication (Invitrogen). pNF-B-d2EGFP vector has a kappa enhancer element (B4) located in the promoter region of a d2EGFP reporter gene (a destabilized variant of the enhanced green fluorescent protein with a half-life of 2 h) (30) . pCEP4 vector expresses a Hygromycin B drug selection marker. The resulting construct pCEP4-NF-B-d2EGFP was transfected into human embryonic kidney 293T cells by using Lipofectamine 2000 (Invitrogen) and normal cell culture media supplemented with 200 g/ml Hygromycin B (Invitrogen) was used to establish the cell line 293T/NF-B-d2EGFP.
Cell Culture. 293T/NF-B-d2EGFP cells were grown in DMEM with 10% FBS (Omega), 500 IU/ml Penicillin (Cellgro), 500 g/ml Streptomycin (Cellgro) supplemented with 200 g/ml Hygromycin B in 5% CO2 at 37°C. The cells have a doubling time of Ϸ1 day and we split them every 3-4 days to avoid confluence. For 96-well-plate experiments, cells were cultured in the plate overnight and allowed to reach Ϸ80% confluence. The cells were stimulated with the appropriate concentration of cytokines for 1 h and washed with fresh media. Fluorescence measurements were performed 7 h after stimulations, when the fluorescence intensity reaches maximum value.
Microfluidics.
A microfluidic platform has been developed to implement the closed-loop optimization approach. Microfluidic channels were fabricated by micromolding of polydimethylsiloxane (PDMS) (Sylgard, 184) on photoresist master. The masters for micromolding were fabricated by photolithography of positive photoresist SJR 5740 (MicroChem, 41001). Three layers of photoresist were spun on the glass substrate to achieve a final thickness of 60 m. After curing, the PDMS replicas were carefully peeled off from the master. The channels were sealed with a 0.17-mm-thick cover glass. The PDMS replicas and the glass pieces were oxidized for 1 min in a plasma cleaner (Harrick, PDC-001). The two layers were immediately brought into contact to achieve irreversible sealing of the channels.
The microfluidic channel is loaded inside a closed chamber (Instec Inc., HCS60-STC20A) with temperature control, adjusted to 37°C during cell culture experiment. The chamber is supplied with 5% CO2 mixed with air. The diffusivities for O2 and CO2 in PDMS are 4.1 ϫ 10 Ϫ5 and 2.6 ϫ 10 Ϫ5 cm 2 /sec, respectively. More information is available in the SI Appendix.
Principle of the Gur Game
The principle of the Gur Game (1) is based on biased random walks of finite-state automata (a set of drugs). The automata describe a set of drugs with assigned concentration values and a set of rules is included for determining how the concentration of the drug switches from one value to the other. Each drug concentration is referred as a state of the automaton. The overall goal of the automata design is to have the drugs to self-organize (choose the optimal concentrations) in an attempt to maximize the overall system performances (desired biological responses indicated by biomarkers). The biological response is transformed into a reward function, which describes the probability of the drug to switch between different concentrations.
To understand the principle of the Gur Game algorithm, it is helpful to consider an example for choosing the concentration of a drug to maximize the antiviral activity (AVA). We design a finite-state automaton with only two states, i.e., one drug with two concentrations (SI Fig. 7 ).
Assuming the two concentrations, C1 and C2, of the drug will give antiviral activities of AVA 1 and AVA 2 , respectively. A reward function can be defined to map AVA 1 and AVA 2 to probabilities of r 1 and r 2 of the drug to be rewarded. For example, the percentage of cells not being infected (the AVA) can be considered to be the probability of the drug being rewarded (i.e., the reward function). At each iteration, the drug can either be awarded or penalized. If the concentration C1 is applied, then the drug will have a chance of r 1 to be rewarded. The drug then has a probability of (1 -r 1 ) and (1 -r 2 ) to receive a penalty in the corresponding states. If the drug is rewarded, it chooses to keep the same concentration. Otherwise, the drug concentration will be switched from one concentration to the other. Because a concentration that gives higher AVA will have higher chance to be rewarded, the drug concentration will have a higher chance to stay in a concentration with high AVA. If the drug concentration gives a low AVA, the drug will have a high chance to be switched to the other concentration. In general, this design encourages the drug to choose a concentration with high AVA because the drug has a higher chance of being rewarded. The drug concentration stays the same if the automaton (drug) is rewarded. Otherwise (penalized), the drug is switched to the other concentration.
The asymptotic behavior of the drug can be modeled by using the Markov chain analysis (2). We define π 1 and π 2 to be the steady-state probabilities of being in drug concentrations of C1 and C2, respectively. The fact that the probabilities sum to unity gives Eq. 1 (the drug chooses either C1 or C2). Equating the transition probabilities (switching from one concentration to the other) leads to Eq. 2. Solving the equations gives the steady-state probability of choosing C2 in Eq. 3. If we assume drug concentrations, C1 and C2, give AVA of 0.4 and 0.8 and the AVA is directly defined as the reward probability (i.e., r 1 = 0.4 and r 2 = 0.8,), the steady state probability of the drug to choose the concentration C2 will be 0.75, whereas the probability of choosing the concentration C1 is 0.25. Therefore, the drug chooses C2 (high AVA) three times more often than C1 (low AVA). In other words, the drug self-organizes to spend more time in a concentration with a higher AVA level.
The same idea can be extended to the general case of a drug with multiple concentrations. In general, the drug moves to the system state toward the center of the state space if penalized, and away from the center if rewarded (see SI Fig. 8 ). This design allows the drug to "detect" promising trends of drug concentrations. SI Fig. 8 shows a drug with 2n states (from -n to +n) and each state is assigned with a different concentration. If the drug is rewarded, the automaton moves from state i to i + 1 if i is positive or from i to i -1 if i is negative. The automaton stays in state n or -n if it is in either one of those states. For a penalty, it moves from state 1 to -1 or vice versa if it is at one of the state, otherwise it moves from state i to i -1 if i is positive, or from i to i + 1 if i is negative. If a low drug concentration has a high AVA (being reward), the automaton attempts to further improve the performance by searching for even lower concentrations. If the drug concentration goes too low and the drug has a high chance to be penalized, the drug concentration will be driven back to a relatively higher concentration. In the case of multiple drugs, the drugs collectively search for a mixture with high AVA (being reward). This framework provides a very rapid and robust control approach for optimizing drug combinations.
For complete details, the reader is referred to original discussions of the Gur Game (1-4). 
Implementation of the Gur Game
Flowchart Representation of the Gur Game. SI Fig. 9 shows a flowchart representation of the Gur Game applied in this study. The study started with initiation of the concentrations of a mixture. Then, an experiment using the drug mixture was performed to estimate the reward value (the probability of the drug being rewarded or penalized). In the VSV experiment, the reward value was estimated according to the percentage of cells not expressing GFP (i.e., not infected by the virus). In the NF-κB experiment, the peak GFP intensities were normalized to map the system state from 0 to 1 with high GFP intensities corresponding to values nearer 1. The GFP value was the average fluorescence intensity of individual cells measured by a 16 bit cooled CCD camera (Photometric CH350L). Intensity values of individual cells were measured by using ImageJ. The GFP data are the average response of ≈100 cells. The data are normalized to be the reward value. The normalization value was determined experimentally and iteratively such that the reward value is between 0 and 1. A random number from 0 to 1 was generated and was compared with the reward value for each automaton. A set of predefined rules of the automata design were used to determine the drug concentrations in the subsequent iteration to probabilistically drive the drugs toward viral inhibition or high NF-κB activity. The concentrations of the drugs were then determined for the next iteration. The process is repeated for each drug during each iteration. The process can be terminated when the system states are spending a large portion of time in some states and/or when a preset performance of the system is reached. Otherwise, a new iteration is initiated and the process repeats. Table 5 ). For set 1 and set 2, initial concentrations were zero for all agents and random initializations were applied for set 3 and set 4. Cytokine Concentrations for Regulating NF-κ κ κ κB Activity. In this Gur Game implementation,
we assigned a different drug concentration to each state of the automaton. This allows for a search technique that rapidly moves around the search space and is less likely to be trapped in any one state. All cytokines were represented by automata with 10 discrete states (0, 0.25, 0.5, 1, 2.5, 5, 10, 25, 50, and 100) ng/ml, which span across three orders of magnitude, in the NF-κB experiment (SI Table 6 ). The states of automata were designed for maximizing the range of cytokine concentrations being tested while maintaining the resolution for searching the optimal cytokine concentration. During each iteration, a random number was generated for each automaton. The numbers were compared with the reward value. If the reward value was greater than the random number, the automaton was rewarded. Otherwise, the automaton was penalized.
The automaton then decided the state in the next iteration according to the automaton design. In general, the state moves toward the center if penalized and away from the center if rewarded. 
Characteristics of the Gur Game Algorithm
In most biological systems, a complete model of the governing network is often not available and only partial information of the system of interest is known. The Gur Game provides a generic mechanism for regulating these complex systems without the requirement of a preassumed model of the system or knowledge of how the system performance depends on the variables being manipulated. Unlike gradient search methods, the Gur Game drives the system state to higher performance probabilistically, instead of deterministically. The probabilistic characteristic of the Gur Game allows the system state to "escape" from local optima and search for the global optimum in the search space. For the same reason, the algorithm performs robustly in a noisy environment. This robustness is critical for controlling biological systems, which are intrinsically noisy (5).
Another important characteristic of the Gur Game is that the optimality is determined by the average behavior (1, 2). The automata states spend more time at states with high reward probability, i.e., good system performance. There is no dynamic difference between the transient behavior of the system and its steady-state behavior. This feature enables the system to respond to a changing population and/or reward function. It is interesting to compare this characteristic with the robustness in cellular functions (6) . In general, the automata and the reward function (mapping between the system performance and reward probability) should be adjusted to fine tune the balance between the robustness, converging rate, and the ability to escape from local traps (1, 2). For distributed control and other self-organizing systems, it is preferable to have small step size such that the system locks into desire behaviors (4). The trade-off is that more steps are required for the system to reach to an optimal solution. For searching and optimization experiments, increasing the "randomness" with larger step size improves the chance that the automata will escape from local optima and rapidly search for the global solution (7).
Reward Function and Automata Design
Reward Function. A key concept in the Gur Game is the reward function, which is a global figure of merit. Basically, the reward function is a measurement of the system performance as a whole. Similar concepts can be found in other optimization approaches. For instance, it is called a fitness function in genetic algorithms (8) and an energy function in simulated annealing (9) . It is one of the most important parts for the success of a closed-loop optimization experiment. The design of a reward function critically determines how well the algorithm is able to solve the problem. In the VSV experiment, the reward function is the percentage of cells not being infected (indicated by GFP expression). In the NF-κB experiment, the reward function is estimated by the NF-κB activity (indicated by the fluorescence intensity). A deep appreciation of the reward function not only provides the scientist extra freedom to improve the search but also broadens the applicability to a wide class of biological systems. To design a reward function, a set of systemic output indicators should be defined. In most cases, phenotypic responses such as proliferation rates, gene expressions, and differentiation efficiency can be directly considered as the reward function. It should also be noted that the reward function can be nonlinearly mapped to the system performance to improve the search efficiency and the converging rate. In general, the reward function of the system can be multimodal, nonlinear, and even discontinuous.
Automata Design. As discussed, the design of the automata is an important component in the realization of the optimization process. Concentration of drugs (states of the automata) can be assigned depending on the range of the drug concentrations intended to be explored. The values can be linear, logarithmic, or other nonlinear functions depending on the nature of the problem.
The number of states should be designed according to the requirements of the converging rate, randomness, and resolution. Unlike, surrogate-based optimization, experimental implementation of a closed-loop optimization scheme does not require "training" of inputs. Extension of the input ranges (drug selection and concentration) can be performed by including extra automata and states of the automata. Another advantage of the stochastic search algorithm is that the converging rate is usually maintained during extension of the input ranges.
Systems with Multiple Outputs. For optimizing multiple parameters, the vector norm or a weighted average of these parameters can be applied to optimize the overall performance. Other schemes can also be applied to account for multiple output parameters. In general, the more information, such as some key molecular components, that is known about the system, the easier to design the experiment. Unfortunately, these parameters are usually not clear and the reward functions in some problems may not be straightforward. Most cases require a slight modification of the problem to define the reward function. If necessary, multiple generations of the closedloop optimization experiment can be performed systemically to identify the appropriate reward functions. In the current study, we have demonstrated the optimization of two different biological systems. Other examples of the implementation of the Gur Game can be found elsewhere (1, 2).
Microfluidic Channel and Cell Culture
Microfluidic Cell Culture System. The microfluidic channel is integrated into a cell culture chamber (Instec Inc, HCS60-STC20A) with temperature control at 37°C. The chamber is mounted on a fluorescence microscope (Nikon TE200) for real-time monitoring. Fluorescence images were captured with a 1024 × 1024 pixel, 16-bit cooled CCD camera (Photometric CH350L). Mini peristaltic pumps (Instech Inc, P625-10638), pressure transducer (Honeywell, ACSX05DN), and temperature probe (Omega, DP460) were connected to the chamber and were centrally controlled by a Labview software (National instruments). The entire setup was sitting inside a vertical clean bench, which prevents contamination from the environment (SI Fig. 10 ). 
